Cumberland Pharmaceuticals Inc. (CPIX) Total liabilities 2016–2025
Cumberland Pharmaceuticals Inc. (CPIX) total liabilities at each fiscal year-end, per SEC filings.
$52.3MFY2025 · since FY2016: $20.3M → $52.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $52.3M | -1.4% |
| FY2024 | $53.0M | +1.0% |
| FY2023 | $52.5M | -7.8% |
| FY2022 | $57.0M | +36.1% |
| FY2021 | $41.9M | -15.6% |
| FY2020 | $49.6M | -7.2% |
| FY2019 | $53.5M | -6.4% |
| FY2018 | $57.1M | +94.9% |
| FY2017 | $29.3M | +44.5% |
| FY2016 | $20.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CPIX financial trends
CPIX RevenueCPIX Net incomeCPIX Net marginCPIX Gross profitCPIX Gross marginCPIX Operating incomeCPIX Operating marginCPIX Operating cash flowCPIX Free cash flowCPIX Capital expendituresCPIX Return on equityCPIX Stock buybacksCPIX Dividends paidCPIX Total assetsCPIX Shareholders’ equityCPIX overview →